Keine speziellen Daten für Kinder verfügbar.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Allgemein
Dimenhydrinat ist in Form von Tabletten, überzogenen Tabletten, Retardkapseln, Kautabletten/-gummi, Sublingualtabletten, Sirupen, Injektionslösungen und Suppositorien verfügbar.
Der Wirkstoff liegt stets als Reinform vor, worauf sich auch die Dosisangabe bezieht.
Orale Anwendung
Tabletten/ überzogene Tabletten/ Retardkapseln
Anwendungshinweis:
Zur Prophylaxe von Kinetosen erfolgt die erstmalige Gabe ca. ½–1 Stunde vor Reisebeginn. Zur Therapie von Übelkeit und Erbrechen werden die Gaben in regelmäßigen Abständen über den Tag verteilt. [11]
Präparate im Handel (Beispiele):
| Präparat | Arzneiform | Stärke | Problematische Hilfsstoffe | Ref. |
| Vomex A Dragees | Überzogene Tabletten | 50 mgT0 | Lactose (Stoffmenge unklar) | [11] |
| Vomacur | Tabletten | 50 mgT2,M | Lactose (40 mg Lactose-Monohydrat/Tbl.) | [10] |
| Reisetabletten STADA | Tabletten | 50 mgT2,M | Lactose (Lactose-Monohydrat 40 mg/Tbl.) | [6] |
| Vomex A Retardkapseln | Retardkapseln | 150 mgT0 | -- | [2] |
| Vertigo-Vomex SR | Retardkapseln | 120 mgT0 | -- | [3] |
M = mörserbar; T0 = nicht teilbar; T2 = dosisgleich teilbar
Kautabletten/ Sublingualtabletten/ Sirupe
Präparate im Handel (Beispiele):
| Präparat | Arzneiform | Stärke | Problematische Hilfsstoffe | Aroma | Ref. |
| Superpep Reise Kaugummi-Dragées | Kautabletten | 20 mg | Aspartam, Saccharin-Natrium | Pfefferminz | [12] |
| Vomex A Reise | Sublingualtabletten | 50 mg | Aspartam, Saccharin-Natrium | Vanille-Menthol | [7] |
| Vomex A Sirup | Sirup | 330 mg/100 ml | Propylenglycol | Kirsche | [1] |
Intravenöse/intramuskuläre Anwendung
Präparate im Handel (Beispiele):
| Präparat | Stärke | Problematische Hilfsstoffe | Ref. |
| Vomex A i.m. Injektionslöung | 100 mg/2 ml | Benzylalkohol (52,5 mg/1 ml), Propylenglycol (520 mg/1 ml) | [13] |
| Vomex A i.v. Injektionslösung | 62 mg/10 ml | -- | [13] |
| Dimenhydrinat Rotexmedica Injektionslösung (i.m.) | 50 mg/ml | Benzylalkohol (52,5 mg/1 ml), Propylenglycol | [8] |
| Dimenhydrinat Rotexmedica Injektionslösung (i.v.) | 62 mg/10 ml | -- | [4] |
Zur Infusion kann Dimenhydrinat-Injektionslösung (i. v.) in folgende Infusionslösungen gegeben werden:
Inkompatibilitäten können auftreten, wenn Dimenhydrinat-Injektionslösung mit Lösungen der folgenden Arzneistoffe gemischt wird:
Rektale Anwedung
Suppositorien
Alle im Handel verfügbaren Suppositorien sind auf Hartfettbasis.
Präparate im Handel (Beispiele):
| Präparat | Stärke | Ref. |
| Vomex A Kinder-Suppositorien | 40 mg | [9] |
| Vomex A Kinder-Suppositorien forte | 70 mg | [9] |
| Vomex A Suppositorien | 150 mg | [9] |
| Vomacur Zäpfchen | 40 mg / 70 mg | [5] |
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Prophylaxis and symptomatic therapy of nausea and vomiting, especially kinetosis |
|---|
|
| CAUTION: |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Studies have shown that administrating dimenhydrinate to infants and young children for the treatment of banal gastroenteritis has no benefit compared with substitution with liquid and electrolytes alone. In view of the frequent occurrence of serious side effects in children up to three years of age in this indication, dimenhydrinate should not be used for the treatment of banal gastroenteritis in this agegroup.
Since dimenhydrinate can cause a seizure, particularly in small children, and this group of patients also tends to have febrile seizures, dimenhydrinate should not be given for febrile infections.
Only use if clearly indicated in children up to 3 years. The recommended maximum dose for this age group should never be exceeded.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Aminoalkyl ethers | ||
|---|---|---|
| R06AA04 | ||
| R06AA02 | ||
| Substituted alkylamines | ||
|---|---|---|
| R06AB03 | ||
| Phenothiazine derivatives | ||
|---|---|---|
| R06AD01 | ||
| R06AD08 | ||
| R06AD02 | ||
| Piperazine derivatives | ||
|---|---|---|
| R06AE07 | ||
| R06AE03 | ||
| R06AE09 | ||
| R06AE05 | ||
| Other antihistamines for systemic use | ||
|---|---|---|
| R06AX18 | ||
| R06AX29 | ||
| R06AX02 | ||
| R06AX27 | ||
| R06AX26 | ||
| R06AX17 | ||
| R06AX13 | ||
| R06AX25 | ||
| R06AX28 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.